Huston Street visits Dr. James Andrews

0 Comments

huston street headshot rockies.jpgJust don’t call it a setback. According to what Rockies general manager Dan O’Dowd told Troy E. Renck of the Denver Post, Huston Street was simply seeking a second opinion on his nagging right shoulder.

“Everything looked great. I was told they
didn’t see any issues at all, so we are going to keep doing the same
thing with him,” O’Dowd said after the Rockies’ 5-3 opening day win over
Milwaukee. “He wanted a second opinion and everything came
back good.”

Street has already suffered multiple setbacks due to inflammation on his right shoulder this spring. According to Renck, Street plans to push ahead with his current program of strengthening the shoulder. He’ll have to progress to playing catch and throwing bullpen sessions before he embarks on a minor league rehab assignment. Given his previous setbacks, we shouldn’t count on him jumping these hurdles before the start of May.

In the interim, Franklin Morales will continue to serve as closer. Not surprisingly, the young left-hander was shaky in his first save opportunity against the Brewers on Monday, hitting Rickie Weeks and throwing a wild pitch, however he was eventually able to shut the door. He’ll make things interesting over the next few weeks, but Morales has the powerful stuff to dominate.
   

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
0 Comments

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.